{
    "code": "01021020",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01021020",
    "time": "2018-05-11 03:55:11",
    "許可證字號": "衛署藥製字第021020號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/03\/18",
    "發證日期": "69\/03\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102102002",
    "中文品名": "&quot;應元&quot;奧菲那特林注射液",
    "英文品名": "ORPHENADRINE INJECTION &quot;Y.Y.&quot;",
    "適應症": "肌肉僵硬、疼痛、扭傷、局部肌肉損傷、纖維織炎、椎間盤脫出、非關節性風濕症、腰背症、斜頸、骨折、外科手術後焦慮緊張",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "ORPHENADRINECITRATE"
    ],
    "限制項目": "01國　產",
    "申請商名稱": "1704519200  應元化學製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "1704519300  應元化學製藥股份有限公司",
        "製造廠廠址": "台南市南區新忠路２６號",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208003420",
            "成分名稱": "ORPHENADRINE CITRATE",
            "含量描述": "30",
            "含量": "30.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "N-020奧菲那特林注射液-仿單-107-03-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01021020&Seq=001&Type=9"
        }
    ]
}